Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Impetigo
ADR ID BADD_A02262
ADR Hierarchy
11      Infections and infestations
11.01      Infections - pathogen unspecified
11.01.12      Skin structures and soft tissue infections
11.01.12.006      Impetigo
23      Skin and subcutaneous tissue disorders
23.09      Skin and subcutaneous tissue infections and infestations
23.09.01      Skin and subcutaneous tissue bacterial infections
23.09.01.006      Impetigo
Description A common superficial bacterial infection caused by STAPHYLOCOCCUS AUREUS or group A beta-hemolytic streptococci. Characteristics include pustular lesions that rupture and discharge a thin, amber-colored fluid that dries and forms a crust. This condition is commonly located on the face, especially about the mouth and nose. [MeSH]
MedDRA Code 10021531
MeSH ID D007169
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Impetigo | Impetigo contagious | Impetigo NOS | Rash impetiginous | Secondary impetigo | Impetigo Contagiosa
ADR Related Proteins
Protein Name UniProt AC TTD Target ID
Not AvailableNot AvailableNot Available
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00066Alendronic acid0.000202%
BADD_D00156Apremilast0.001158%
BADD_D00349Capecitabine0.000533%
BADD_D00680Dimethyl fumarate0.001834%
BADD_D00809Escitalopram--
BADD_D00931Fluorouracil0.001882%
BADD_D00945Fluticasone--
BADD_D00947Fluticasone propionate--
BADD_D01158Ingenol mebutate0.019598%
BADD_D01230Ketoconazole--
BADD_D01243Lamotrigine0.000387%
BADD_D01250Lasofoxifene--
BADD_D01617Ondansetron0.000699%
BADD_D01637Oxcarbazepine--
BADD_D01773Pimecrolimus--
BADD_D01933Ribavirin0.063458%
BADD_D02001Secukinumab--
BADD_D02093Sulfasalazine0.002072%
BADD_D02105Tacrolimus0.001419%
BADD_D02120Tazarotene--
BADD_D02378Zalcitabine--
BADD_D02450Crisaborole0.001318%
BADD_D02464Fingolimod0.001158%
The 1th Page    1    Total 1 Pages